Sanofi-Genzyme deal may wrap next week

The French newspaper Le Figaro weighed in with its own insider account of the Sanofi-Genzyme merger talks, speculating that the deal could get wrapped up early next week--provided, of course, both sides continue to narrow the gap that exists between what Sanofi is willing to pay in cash and what it promises in milestones. Report

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.